Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Tiaprofenic acid
Beaumont Pharma Ltd
M01AE11
Tiaprofenic acid
300mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100; GTIN: 5013841101466
_créé le_ _par_ _modifié le_ _par_ 15/10/2020 DERIGNY C 15/09/2021 DERIGNY C SANOFI GRANDE-BRETAGNE _Laboratoires_ _Pays_ _Couleur_ _Nbre/Réf._ _Version N°_ _Type Article_ _Nom du produit_ _Référence article_ _Dosage_ _Quantité_ _N° version Logo/Name_ _N° version Country Ex._ _N° plan Dimensionnel_ _N° plan positionnement_ _Dimensions_ _Taille mini caractères_ _Code sécurité_ R789740 N.A. CRGB - V1 - 05/2012 1-606062 606062-1D 150 X 210 MM 9 PTS 8 NOTICE DOUBLE SURGAM R789740 300 MG CPRS 1 BLEU REFLEX BLUE U _Numéro de pages_ 1/4 - 1 - R789740 IS THIS LEAFLET HARD TO SEE OR READ? PHONE 0800 035 2525 FOR HELP READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What SURGAM is and what it is used for 2. What you need to know before you take SURGAM 3. How to take SURGAM 4. Possible side effects 5. How to store SURGAM 6. Contents of the pack and other information 1. WHAT SURGAM IS AND WHAT IT IS USED FOR The name of your medicine is SURGAM 300 mg Tablets (called SURGAM in this leaflet). SURGAM contains a medicine called tiaprofenic acid. This belongs to a group of medicines called ‘non-steroidal anti- inflammatory drugs’ (NSAIDs). It works by blocking some chemicals in your body that normally cause inflammation. It is used to treat the swelling, pain, heat, redness and stiffness in your joints and muscles in the following: • Rheumatoid arthritis (inflammation of the joints) • Osteoarthritis (where the cushioning (cartilage) between the bone joints is damaged) • Lower back pa Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Surgam Tablets 300mg. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 300 mg Tiaprofenic Acid. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, low back pain, musculo- skeletal disorders such as fibrositis, capsulitis, epicondylitis and other soft-tissue inflammatory conditions, sprains and strains, post-operative inflammation and pain and other soft tissue injuries. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults 600 mg daily in divided doses: • 300mg twice a day. • Alternatively, 200mg three times a day._ _ Elderly As for adults (see section 4.4). NSAIDs should be used with particular caution in older patients who are at increased risk of the serious consequences of adverse reactions. In cases of renal, cardiac or hepatic impairment, the dosage should be kept as low as possible. It is suggested that in such cases, the dosage be reduced to 200 mg twice daily. If an NSAID is considered necessary, elderly patients should receive the lowest effective dose for the shortest possible duration and be monitored regularly for gastrointestinal bleeding for following initiation of NSAID therapy. Paediatric population There are insufficient data to recommend use of Surgam in children. Method of administration • For oral administration. • To be swallowed whole. • To be taken preferably with or after food. 4.3 CONTRAINDICATIONS - Active or history of recurrent peptic ulcer/hemorrage (two or more distinct episodes of proven ulceration or bleeding). - History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. - Active bladder or prostatic disease or symptoms. - History of recurrent urinary tract disorders. - Hypersensitivity to tiaprofenic acid or to any of the excipients. - NSAIDs are contraindicated in patients who have previously shown hypersensitivity Read the complete document